Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
TB-500 (derived from Thymosin Beta-4) supports cell migration and new blood-vessel formation while reducing inflammation
Information derived from existing preclinical literature
Key benefits Why people compare it 1 40-60% greater healing outcomes versus either peptide alone 2 Simultaneous activation of early-phase (TB-500) and mid-phase (BPC-157) repair 3 Synergistic upregulation of both VEGF/EGF and actin-migration pathways 4 Dual anti-inflammatory action: NO system modulation plus cytokine reduction 5 Single-vial reconstitution eliminates dosing variability 6 Optimized 1:1 mass ratio matching published combination protocols 7 Thorough tendon, ligament, muscle, and joint repair support 8 No emergent toxicity beyond individual component profiles Deep research About BPC-157 / TB-500 Blend This blend combines two structurally and mechanistically distinct peptides: BPC-157 (a 15-amino acid pentadecapeptide, MW ~1419 Da, sequence GEPPPGKPADDAGLV) and TB-500 (a synthetic 43-amino acid replica of Thymosin Beta-4, MW ~4921 Da)
Frequently asked questions Q: How many doses in a 5mg vial
Lastly, a sharps container for safely disposing of your needles and syringes afterward
Knowing these differences helps healthcare providers and patients make better choices
US$ 20.52
US$ 22.03
US$ 24.77
US$ 21.53
US$ 24.34
